Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis

Gut. 1990 Feb;31(2):184-6. doi: 10.1136/gut.31.2.184.

Abstract

The aim of the present study was to investigate the effects of 5-aminosalicyclic acid (5-ASA) on the cell injury mediated by activated neutrophils. We used a system constituted of neutrophils, triggered with phorbol myristate acetate, and 51Cr-labelled Daudi cells as targets. The results show that 5-ASA is capable of efficiently preventing neutrophil-mediated lysis. 5-ASA was up to 10-fold more effective than taurine, which acts as an hypochlorous acid scavenger. Moreover, 5-ASA was found to compete with taurine for the neutrophil derived hypochlorous acid. The results are consistent with the conclusion that 5-ASA is capable of limiting the neutrophil mediated cell damage by scavenging the generated hypochlorous acid. This may represent a potential mechanism for the therapeutic action of 5-ASA in ulcerative colitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminosalicylic Acids / pharmacology
  • Aminosalicylic Acids / therapeutic use*
  • Cells, Cultured
  • Colitis, Ulcerative / drug therapy*
  • Cytotoxicity Tests, Immunologic
  • Humans
  • Hypochlorous Acid / antagonists & inhibitors*
  • Mesalamine
  • Neutrophils / drug effects
  • Neutrophils / physiology*
  • Oxygen Consumption / drug effects

Substances

  • Aminosalicylic Acids
  • Mesalamine
  • Hypochlorous Acid